Opinion|Videos|October 4, 2024

Impact of Transplant Eligibility on Treatment Selection

Panelists discuss how transplant eligibility significantly influences first-line treatment goals and initial therapy selection in multiple myeloma, often leading to more intensive induction regimens aimed at achieving deep remissions.

Video content above is prompted by the following:

  • How does transplant eligibility impact first-line treatment goals and selection of initial therapy?

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME